Sebastian N. Geiger

TL;DR: The observation that participation can be increased by offering non-invasive tests, and that a blood test is the preferred option should be validated in a prospective trial in the screening setting is validated.

TL;DR: The data suggest that metallic stenting is a valid option for the treatment of malignant esophageal conditions, even when survival longer than 6 months is expected, and only performance status was a risk factor for AEs.

TL;DR: First, pCLE is highly accurate for real-time histology of Lugol-unstained esophageal lesions in patients with HNC and may alter the management of patients under surveillance for ESCC, guiding biopsies and endoscopic resection, avoiding further diagnostic workup or therapy of benign lesions.

TL;DR: The push and introducer PEG techniques seem to be both safe and effective but present different complication profiles, and the choice of PEG technique in patients with HNC should be made individually.

TL;DR: Melanoma, lung, and breast cancer were the most common primary tumors to metastasize to the GI tract and patients who received palliative treatment with chemo- and/or radiotherapy after diagnosis of GI metastasis had higher survival rates.